ArticleFrontiers in immunology2023

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.

Maria Rescigno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.